BWAY
BrainsWay Ltd.
NASDAQ · Healthcare · Medical - Devices · IL
$13.61
+0.59%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$13.61
From 52W high−20.73%
Volume47196.00
Market cap$547.67M
P/E (TTM)29.6x
P/S (TTM)9.0x
Div yield—
Key dataSep 18, 2026
Open
$13.61
From 52W high
−20.73%
Volume
47196.00
Market cap
$547.67M
ValuationView details →
P/E (Fwd)
33.5x
EV/EBITDA
40.4x
P/E (TTM)
29.6x
RSI (14)
37.5
MomentumView details →
1D Return
+0.59%
YTD Return
+42.22%
SummaryUpdated Jun 1, 2026
BrainsWay Ltd. (NASDAQ:BWAY) is an Israeli medical device company founded in 2003 and headquartered in Jerusalem. The company went public on NASDAQ in April 2019. BrainsWay develops and commercializes Deep Transcranial Magnetic Stimulation (Deep TMS) technology, a non-invasive neurostimulation treatment platform for various mental health and neurological disorders. The company has evolved from a research-focused startup to a profitable medical device manufacturer with over 1,350 systems installed globally and a growing presence in both domestic U.S. and international markets.
Similar companies
Latest newsMore news →